CREATIVE BIO-PEPTIDES, INC.
Improving patients' lives by challenging conventions in neurodegenerative disease treatment
POTOMAC, United States · Founded 2019 · $5.8M raised
- Headquarters
- POTOMAC, Maryland
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2G
- Website
- creativebiopeptides.com
- Total Funding
- $5.8M
- Last Round
- $5.8M GrantJul 2025
- Rounds
- 1
About
Creative Bio-Peptides (CBP) is a biopharmaceutical company developing orally-active chemokine antagonist peptides for neurological and pain conditions. Their lead compound RAP-103 targets chronic pain, neuropathies, cognitive decline in dementias, and opioid use disorders. Founded by NIH scientists, CBP's pipeline is backed by over $75M in legacy research and funded primarily through NIH SBIR grants.
Summary
CREATIVE BIO-PEPTIDES, INC. is a Biotech company based in POTOMAC, United States, founded in 2019. It has raised $5.8M in total across 1 round, most recently a $5.8M Grant round in Jul 2025. Investors include National Institute on Aging.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company